A former CEO raised money from investors without promised oversight from a board or auditor and misappropriated at least $500,000 in client funds, the Securities and Exchange Commission said.
Derek R. Taller engaged in “persistent and egregious” fraudulent conduct from January 2020 to October 2022 while managing and advising two investment vehicles, an unregistered fund called Vision BioBanc Holdings LLC and business development company StHealth Capital Investment Corp., the SEC said in a lawsuit filed Tuesday in the US District Court for the Southern District of New York.
Taller disseminated offering documents to prospective investors with misrepresentations about oversight of ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.